France
# |
Name |
Shares (Diluted, Weighted) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
1,256,400,000
|
Dec. 31, 2023 | USD 96.09 | -1.23% |
|
France |
|
2 |
138,624,381
|
Dec. 31, 2023 | USD 2.16 | -2.19% |
|
France |
|
3 |
118,802,462
|
Dec. 31, 2023 | USD 110.89 | -1.59% |
|
France |
|
4 |
110,000,000
|
June 30, 2024 | USD 12.99 | 0.21% |
|
France |
|
5 |
95,121,390
|
Dec. 31, 2023 | USD 4.64 | -14.23% |
|
France |
|
6 |
94,200,000
|
Dec. 31, 2023 | USD 3.26 | 2.55% |
|
France |
|
7 |
92,160,626
|
Dec. 31, 2023 | USD 208.18 | -0.28% |
|
France |
|
8 |
83,375,212
|
Dec. 31, 2023 | USD 122.64 | 0.35% |
|
France |
|
9 |
80,453,282
|
Dec. 31, 2023 | USD 1.88 | -0.49% |
|
France |
|
10 |
75,043,514
|
Dec. 31, 2023 | USD 74.26 | 0.89% |
|
France |
|
11 |
70,626,248
|
Dec. 31, 2023 | USD 0.68 | -1.49% |
|
France |
|
12 |
57,012,815
|
Dec. 31, 2023 | USD 1.74 | -2.29% |
|
France |
|
13 |
49,700,223
|
Dec. 31, 2023 | USD 3.40 | -0.30% |
|
France |
|
14 |
47,971,121
|
June 30, 2024 | USD 3.36 | -0.01% |
|
France |
|
15 |
45,351,799
|
Dec. 31, 2023 | USD 2.29 | 4.37% |
|
France |
|
16 |
43,066,012
|
Dec. 31, 2023 | USD 6.25 | -0.54% |
|
France |
|
17 |
38,159,930
|
Dec. 31, 2023 | USD 2.22 | -0.32% |
|
France |
|
18 |
36,996,722
|
Dec. 31, 2023 | USD 2.02 | -2.42% |
|
France |
|
19 |
36,928,161
|
Dec. 31, 2023 | USD 3.05 | 0.95% |
|
France |
|
20 |
29,349,981
|
Dec. 31, 2023 | USD 1.29 | -1.75% |
|
France |
|
21 |
29,091,656
|
Dec. 31, 2023 | USD 1.42 | -0.83% |
|
France |
|
22 |
28,419,502
|
March 31, 2024 | USD 16.86 | 0.98% |
|
France |
|
23 |
22,274,725
|
Dec. 31, 2023 | USD 10.08 | 4.45% |
|
France |
|
24 |
19,562,147
|
Dec. 31, 2023 | USD 6.91 | 0.46% |
|
France |
|
25 |
18,353,179
|
Dec. 31, 2023 | USD 4.74 | -2.78% |
|
France |
|
26 |
17,767,652
|
Dec. 31, 2023 | USD 3.17 | NA |
|
France |
|
27 |
17,362,222
|
Dec. 31, 2023 | USD 27.83 | 2.50% |
|
France |
|
28 |
15,174,125
|
Dec. 31, 2023 | USD 39.47 | -3.91% |
|
France |
|
29 |
13,610,429
|
Dec. 31, 2023 | USD 13.50 | -2.38% |
|
France |
|
30 |
12,898,785
|
Dec. 31, 2023 | USD 2.16 | 6.70% |
|
France |
|
31 |
12,577,893
|
Dec. 31, 2023 | USD 27.36 | -1.07% |
|
France |
|
32 |
12,461,987
|
Dec. 31, 2023 | USD 1.50 | -9.33% |
|
France |
|
33 |
11,832,510
|
Dec. 31, 2023 | USD 71.52 | -1.80% |
|
France |
|
34 |
11,365,004
|
Dec. 31, 2023 | USD 8.53 | 3.61% |
|
France |
|
35 |
11,216,516
|
Dec. 31, 2023 | USD 26.07 | 0.60% |
|
France |
|
36 |
11,080,590
|
Dec. 31, 2023 | USD 6.08 | 1.81% |
|
France |
|
37 |
10,708,985
|
Dec. 31, 2023 | USD 2.27 | 11.78% |
|
France |
|
38 |
10,488,178
|
Dec. 31, 2023 | USD 2.05 | -2.81% |
|
France |
|
39 |
10,451,424
|
Dec. 31, 2023 | USD 1.53 | 0.60% |
|
France |
|
40 |
9,026,058
|
Dec. 31, 2023 | USD 3.97 | 0.60% |
|
France |
|
41 |
8,106,769
|
Dec. 31, 2023 | USD 1.94 | -0.97% |
|
France |
|
42 |
7,460,450
|
June 30, 2024 | USD 23.39 | -1.14% |
|
France |
|
43 |
4,695,135
|
Dec. 31, 2023 | USD 1.82 | 1.18% |
|
France |
|
44 |
3,720,277
|
Dec. 31, 2023 | USD 4.25 | 1.59% |
|
France |
|
45 |
2,849,001
|
Dec. 31, 2023 | USD 4.54 | 0.83% |
|
France |
|
46 |
351,684
|
Dec. 31, 2023 | USD 0.96 | -6.39% |
|
France |
|
47 |
5,044
|
Dec. 31, 2023 | USD 20.08 K | 0.04% |
|
France |
The Pharmaceuticals company in France with the highest Shares (Diluted, Weighted) is Sanofi (Paris Stock Exchange: SAN.PA) at 1,256,400,000.
The Pharmaceuticals company in France with the lowest Shares (Diluted, Weighted) is Eurofins-Cerep SA (Paris Stock Exchange: ALECR.PA) at 5,044.
The top 10 Pharmaceuticals companies in France by Shares (Diluted, Weighted) are Sanofi, Valneva SE, bioMérieux S.A., Ramsay Générale de Santé SA, DBV Technologies S.A., Euroapi S.A., Sartorius Stedim Biotech S.A., Ipsen S.A., Innate Pharma S.A. and Arkema S.A..
The bottom 10 Pharmaceuticals companies in France by Shares (Diluted, Weighted) are Eurofins-Cerep SA, Neovacs S.A., Euromedis Groupe, Predilife S.A., PHAXIAM Therapeutics S.A., Bastide Le Confort Médical SA, NFL Biosciences SA, genOway Société anonyme, Ikonisys S.A. and Advicenne S.A..